The intraocular fluids and sera from three patients with acute retinal necrosis (ARN) and from 120 age-matched controls were tested for the presence of antibodies to herpes simplex virus type I (HSV-I). Antibodies to HSV-I were detected in both intraocular fluids and sera of two cases, and in intraocular fluids alone in one case of ARN. Among 120 control patients undergoing routine intraocular surgery antibodies to HSV-I were detected in the sera of 85 (79.2%) but in the intraocular fluids of only two (1-7%). 
SUMMARY
The intraocular fluids and sera from three patients with acute retinal necrosis (ARN) and from 120 age-matched controls were tested for the presence of antibodies to herpes simplex virus type I (HSV-I). Antibodies to HSV-I were detected in both intraocular fluids and sera of two cases, and in intraocular fluids alone in one case of ARN. Among 120 control patients undergoing routine intraocular surgery antibodies to HSV-I were detected in the sera of 85 (79.2%) but in the intraocular fluids of only two (1-7% 
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also studied blood and intraocular fluid from control patients who were undergoing routine intraocular surgery with no evidence of HSV infection.
Materials and methods
A history of recent cold sores or genital ulceration was sought in each patient. A full ophthalmic and general examination was performed and included the recording of visual acuities and detection of any signs of intraocular inflammation in each eye. A full general examination was carried out, in particular with a search for evidence of oral or genital ulceration.
Two patients with ARN underwent vitrectomy for the treatment of complicated retinal detachment; samples of intraocular fluids were taken during this procedure. In the third case of ARN aqueous was sampled by a diagnostic tap of the anterior chamber.
In control patients intraocular fluid samples were taken peroperatively in such a way as to ensure that the samples were not contaminated by blood. Aqueous was collected from patients undergoing trabeculectomy or routine cataract extraction. When the anterior chamber was first opened, a sterile sponge measuring approximately 5 x2x 1 mm (Spontex Ltd) was saturated with aqueous (approximately 005 ml of fluid being collected). The sponge was then placed in a tightly stoppered dry plastic capsule and stored at +4°C until transferred to the laboratory.
Vitreous was collected via a two-way tap inserted in the aspiration line from the Ocutome vitrectomy NSarkies, Z Gregor, TForsey, and S Darougar machine. A 1-0 ml insulin type syringe was used to withdraw a specimen from the tubing. Subretinal fluid was collected by saturating a sterile sponge of the type used for the collection of aqueous.
Tears were collected from the conjunctival sac of the fellow eye during surgery by means of a dry cellulose sponge. In the patients with ARN and the patients undergoing routine intraocular surgery blood was withdrawn on the same day as intraocular fluid was collected. All specimens were tested for type specific antibodies to HSV-I by an indirect immunofluorescence test.6 Sera were tested for specific IgG at 1/16 or greater and for IgM at 1/8 or above. Other specimens were tested for specific IgG and IgA at 1/8 or greater.
Results
Antibody findings in three patients with acute retinal necrosis are shown in Table 1 . CASE 1 This 55-year-old woman was well until April 1982, when she suddenly developed drowsiness and dysphasia. A diagnosis of herpes encephalitis was made, and she was treated with intravenous acyclovir and then systemic steroids, in reducing dosage. Three months later she complained of blurred vision in her left eye, and examination showed panuveitis with ARN (Fig. 1) . Serum IgG to HSV-I was positive at a titre of 1:16.
She was treated with systemic steroids. Four weeks later she developed a total retinal detachment in her left eye (Fig. 2) . A left vitrectomy, lensectomy, and silicone oil: fluid exchange were performed. Serum IgG antibody to HSV-I had risen to a titre of 1:128. HSV-I IgG was also present at a titre of 1:128 in subretinal fluid. CASE 2 This was a 56-year-old woman who was well until she developed blurred vision in her right eye in September 1982. A diagnosis of ARN was made, and she was treated with intravenous acyclovir. Two months later a total retinal detachment developed in her right eye. A vitrectomy and gas: fluid exchange was performed. Serum IgG antibody to HSV-I was negative. However, IgG to HSV-I was present at a titre of 1:16 in the subretinal fluid and vitreous. We studied 120 consecutive patients undergoing routine anterior or posterior segment intraocular Antibodies to herpes simplex virus type I in intraocularfluids ofpatients with acute retinal necrosis (Table 3) .
Subretinal fluid was collected from 10 patients. In seven patients serum antibody to HSV-I was positive. In none of the tears collected were antibodies to HSV-I present. In one patient subretinal fluid antibody to HSV-I was present at a titre of 1: 32; concurrent serum titre in this patient was also 1:32 (Table 4) .
Discussion
We found antibody to HSV-I in intraocular fluids of three patents with ARN and in two out of 120 (1.7%) of controls.
We consider that there are four possible explanations for the presence of antibody in intraocular fluids. First, the antibody may be produced within the eye. Secondly, it may be produced elsewhere but sequestered in the eye. Thirdly, it may leak from the serum when the blood-ocular barrier is damaged. Fourthly, it may leak into the eye during the sampling procedure.
The presence of higher antibody levels in the aqueous than in the serum has been cited as proof of local antibody production within the eye. Felberg et al reported five cases of ocular toxocariasis in which antibody titres to toxocara canis in the aqueous were significantly higher than the serum.7 They assert that the presence of plasma cells in the eosinophilic abscess which characterises nematode endophthalmitis is suggestive of local production of antibody.
However, there are difficulties making direct comparisons between serum and aqueous without taking account of the different concentrations of IgG. Pedersen and Lorentsen-Styr compared aqueous and serum concentrations of antibody against toxoplasma gondii in 10 patients with active retinochoroiditis.8 According to a formula derived from Desmonts,9 they calculated the aqueous humour antibody coefficient:
Coefficient=antibody titre aqueous x globulin_ serum serum aqueous A titre greater than 1 indicated that aqueous humour globulins were richer in toxoplasma antibodies than the serum. In six out of 10 patients the antibody aqueous humour coefficient was significantly raised. This finding suggests local antibody production within the eye. There have also been reports of autoantibody detected within the aqueous but not in the serum of patients with uveitis. In two patients with chronic anterior uveitis and Still's disease antinuclear antibodies were present in the aqueous but not in the blood.'0 Rheumatoid factor was detected in aqueous but not serum of five patients with endogenous uveitis.'" However, in all these circumstances it is possible that antibody had been sequestered in the eye rather than produced there.
There is indirect evidence of leak of antibody across a damaged blood ocular barrier. The uveal 83 group.bmj.com on April 1, 2017 -Published by http://bjo.bmj.com/ Downloaded from N Sarkies, Z Gregor, TForsey, and S Darougar vessels have been shown to exert a degree of selectivity when albumin-bound trypan blue and colloidal carbon were used as markers.'2 The integrity of this barrier could be compromised after local application of histamine.'3 A similar leak may occur after any episode of intraocular inflammation. Pedersen and Lorentsen-Styr noted a high level of IgG in the aqueous of a patient with active uveitis.8 Antibody leak would certainly explain the finding of antibody to HSV-I in two patients with ARN (cases 1 and 3). In one patient, case 2, antibody to HSV-I was not detected in the serum, implying there was local antibody production or sequestration. However, in this case the titre of antibody in the subretinal fluid and vitreous was low.
Though antibody to HSV-I was present in the sera of 95 out of 120 (79%) patients undergoing routine intraocular surgery, it was present in the intraocular fluids of only two (1-7%) patients. This makes it highly unlikely that the detection of antibody in intraocular fluids was due to contamination during the sampling procedure.
In conclusion, we consider that antibody in intraocular fluid may result from local antibody production or sequestration or damage to the blood ocular barrier. To establish which process is responsible studies of intraocular fluids in inflamed eyes are required. The presence of antibody to HSV-I in the intraocular fluid of patients with ARN is highly suggestive evidence that this virus causes this disease. 
